Natural Killer Cells: Key Players in Endometriosis

American Journal of Reproductive Immunology

Volumn 74, Issue 4, 2015, Pages 291-301

  Thiruchelvam, Uma ^a   Wingfield, Mary ^b,c   O'Farrelly, Cliona ^a,d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL MATERNITY HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Endometriosis; Endometrium; NK cell; UNK

Indexed keywords

CHEMOKINE; CYTOKINE;

ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; ENDOMETRIUM; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFERTILITY, FEMALE; MACROPHAGE; MOUSE; PATHOLOGY; PREGNANCY; UTERUS;

ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; INFERTILITY, FEMALE; KILLER CELLS, NATURAL; MACROPHAGES; MICE; PREGNANCY; UTERUS;

EID: 84941737092     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12408     Document Type: Review

References (113)

1. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM: Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984; 64:151-154.
2. Giudice LC: Clinical practice. Endometriosis. N Engl J Medicine 2010; 362:2389-2398.
3. Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA, Zondervan KT: Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci 2009; 16:335-346.
4. Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco Nardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT: Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011; 96:366-73 e8.
5. Chapron C, Fauconnier A, Dubuisson JB, Barakat H, Vieira M, Breart G: Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease. Hum Reprod 2003; 18:760-766.
6. D'Hooghe TM, Debrock S, Hill JA, Meuleman C: Endometriosis and subfertility: is the relationship resolved? Semin Reprod Med 2003; 21:243-254.
7. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W: ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29:400-412.
8. Von Rokitansky C: Ueber uterusdrusen-neubildung in uterus and ovarilsarcomen. Z Ges Aerzte Wein 1860; 37:577-593.
9. Sampson J: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14:422-469.
10. Blumenkrantz MJ, Gallagher N, Bashore RA, Tenckhoff H: Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstet Gynecol 1981; 57:667-670.
11. Liu DT, Hitchcock A: Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol 1986; 93:859-862.
12. Kjerulff KH, Erickson BA, Langenberg PW: Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health 1996; 86:195-199.
13. Houston DE: Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev 1984; 6:167-191.
14. Houston DE, Noller KL, Melton LJ III, Selwyn BJ, Hardy RJ: Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979. Am J Epidemiol 1987; 125:959-969.
15. Berbic M, Fraser IS: Immunology of normal and abnormal menstruation. Women's Health (Lond, Engl) 2013; 9:387-395.
16. Swann JB, Smyth MJ: Immune surveillance of tumors. J Clin Investig 2007; 117:1137-1146.
17. Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endometriosis. Fertil Steril 2001; 75:1-10.
18. Giudice LC, Kao LC: Endometriosis. Lancet 2004; 364:1789-1799.
19. Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, Masuzaki H: Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am J Reprod Immunol 2008; 60:383-404.
20. Berbic M, Fraser IS: Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011; 88:149-155.
21. Hutter S, Heublein S, Knabl J, Andergassen U, Vrekoussis T, Makrigiannakis A, Friese K, Mayr D, Jeschke U: Macrophages: are they involved in endometriosis, abortion and preeclampsia and how? J Nippon Med Sch 2013; 80:97-103.
22. D'Hooghe TM, Bambra CS, Xiao L, Peixe K, Hill JA: Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus). Am J Obstet Gynecol 2001; 184:917-925.
23. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, Smith SK, Tavaré S, Print CG, Charnock-Jones DS: Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 2008; 173:700-715.
24. Capobianco A, Rovere-Querini P: Endometriosis, a disease of the macrophage. Front Immunol 2013; 4:9.
25. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 2008; 9:503-510.
26. Lysakova-Devine T, O'Farrelly C: Tissue-specific NK cell populations and their origin. J Leukoc Biol 2014; 96:981-990.
27. Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J: CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009; 126:458-465.
28. Sharma R, Das A: Organ-specific phenotypic and functional features of NK cells in humans. Immunol Res 2014; 58:125-131.
29. Hanna J, Mandelboim O: When killers become helpers. Trends Immunol 2007; 28:201-206.
30. Freud AG, Caligiuri MA: Human natural killer cell development. Immunol Rev 2006; 214:56-72.
31. Freud AG, Yu J, Caligiuri MA: Human natural killer cell development in secondary lymphoid tissues. Semin Immunol 2014; 26:132-137.
32. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
33. King A: Uterine leukocytes and decidualization. Hum Reprod Update 2000; 6:28-36.
34. King A, Burrows T, Verma S, Hiby S, Loke YW: Human uterine lymphocytes. Hum Reprod Update 1998; 4:480-485.
35. Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY: Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod 1995; 10:2671-2675.
36. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T: Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 2002; 77:297-302.
37. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I: Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994; 62:1086-1088.
38. Wu MY, Yang JH, Chao KH, Hwang JL, Yang YS, Ho HN: Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 2000; 74:1187-1191.
39. Matsuoka S, Maeda N, Izumiya C, Yamashita C, Nishimori Y, Fukaya T: Expression of inhibitory-motif killer immunoglobulin-like receptor, KIR2DL1, is increased in natural killer cells from women with pelvic endometriosis. Am J Reprod Immunol 2005; 53:249-254.
40. Oosterlynck DJ, Meuleman C, Lacquet FA, Waer M, Koninckx PR: Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis. Am J Reprod Immunol 1994; 31:25-31.
41. Dias JA Jr, Podgaec S, De Oliveira RM, Carnevale Marin ML, Baracat EC, Abrao MS: Patients with endometriosis of the rectosigmoid have a higher percentage of natural killer cells in peripheral blood. J Minim Invasive Gynecol 2012; 19:317-324.
42. Zhang C, Maeda N, Izumiya C, Yamamoto Y, Kusume T, Oguri H, Yamashita C, Nishimori Y, Hayashi K, Luo J, Fukaya T: Killer immunoglobulin-like receptor and human leukocyte antigen expression as immunodiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol 2006; 55:106-114.
43. Maeda N, Izumiya C, Kusum T, Masumoto T, Yamashita C, Yamamoto Y, Oguri H, Fukaya T: Killer inhibitory receptor CD158a overexpression among natural killer cells in women with endometriosis is undiminished by laparoscopic surgery and gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol 2004; 51:364-372.
44. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991; 56:45-51.
45. Tanaka E, Sendo F, Kawagoe S, Hiroi M: Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992; 34:27-30.
46. Kanzaki H, Wang HS, Kariya M, Mori T: Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol 1992; 167:257-261.
47. Lynch L, Golden-Mason L, Eogan M, O'Herlihy C, O'Farrelly C: Cells with haematopoietic stem cell phenotype in adult human endometrium: relevance to infertility? Hum Reprod 2007; 22:919-926.
48. Kikuchi Y, Ishikawa N, Hirata J, Imaizumi E, Sasa H, Nagata I: Changes of peripheral blood lymphocyte subsets before and after operation of patients with endometriosis. Acta Obstet Gynecol Scand 1993; 72:157-161.
49. Young VJ, Brown JK, Saunders PT, Horne AW: The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update 2013; 19:558-569.
50. Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR: The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992; 58:290-295.
51. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR, Vandeputte M: Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993; 82:206-212.
52. Funamizu A, Fukui A, Kamoi M, Fuchinoue K, Yokota M, Fukuhara R, Mizunuma H: Expression of natural cytotoxicity receptors on peritoneal fluid natural killer cell and cytokine production by peritoneal fluid natural killer cell in women with endometriosis. Am J Reprod Immunol 2014; 71:359-367.
53. Hernandez Guerrero CA, Tlapanco Barba R, Ramos Perez C, Velazquez Ramirez N, Castro Eguiluz D, Cerbulo Vazquez A: Endometriosis and discouragement of immunology cytotoxic characteristics. Ginecol Obstet Mex 2003; 71:559-574.
54. Wu MY, Ho HN: The role of cytokines in endometriosis. Am J Reprod Immunol 2003; 49:285-296.
55. Barcz E, Milewski L, Dziunycz P, Kaminski P, Ploski R, Malejczyk J: Peritoneal cytokines and adhesion formation in endometriosis: an inverse association with vascular endothelial growth factor concentration. Fertil Steril 2012; 97:1380-6 e1.
56. Hassa H, Tanir HM, Tekin B, Kirilmaz SD, Sahin Mutlu F: Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet 2009; 279:891-895.
57. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I: Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod 2005; 11:29-34.
58. Milewski L, Barcz E, Dziunycz P, Radomski D, Kaminski P, Roszkowski PI, Korczak-Kowalska G, Malejczyk J: Association of leptin with inflammatory cytokines and lymphocyte subpopulations in peritoneal fluid of patients with endometriosis. J Reprod Immunol 2008; 79:111-117.
59. Tao Y, Zhang Q, Huang W, Zhu H, Zhang D, Luo W: The peritoneal leptin, MCP-1 and TNF-alpha in the pathogenesis of endometriosis-associated infertility. Am J Reprod Immunol 2011; 65:403-406.
60. Scholl B, Bersinger NA, Kuhn A, Mueller MD: Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis. Gynecol Endocrinol 2009; 25:701-706.
61. Lu D, Song H, Shi G: Anti-TNF-alpha treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2013; 3:CD008088.
62. Bellelis P, Barbeiro DF, Rizzo LV, Baracat EC, Abrao MS, Podgaec S: Transcriptional changes in the expression of chemokines related to natural killer and T-regulatory cells in patients with deep infiltrative endometriosis. Fertil Steril 2013; 99:1987-1993.
63. Robertson MJ: Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002; 71:173-183.
64. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H: Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002; 83:149-155.
65. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G: Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1999; 5:642-650.
66. Sturlese E, Salmeri FM, Retto G, Pizzo A, De Dominici R, Ardita FV, Borrielli I, Licata N, Laganà AS, Sofo V: Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol 2011; 92:74-81.
67. Eidukaite A, Siaurys A, Tamosiunas V: Aberrant expression of CD95 and CD69 molecules among CD56 cells in women with endometriosis. Am J Reprod Immunol 2006; 55:276-281.
68. Jeung IC, Chung YJ, Chae B, Kang SY, Song JY, Jo HH, Lew YO, Kim JH, Kim MR: Effect of helixor a on natural killer cell activity in endometriosis. Int J Med Sci 2015; 12:42-47.
69. Maeda N, Izumiya C, Taniguchi K, Matsushima S, Fukaya T: Role of NK cells and HLA-G in endometriosis. Front Biosci (Schol Ed). 2012; 4:1568-1581.
70. Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A: Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis. Fertil Steril 2008; 89(5 Suppl):1490-1496.
71. Vernet-Tomas Mdel M, Perez-Ares CT, Verdu N, Molinero JL, Fernandez-Figueras MT, Carreras R: The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women. Fertil Steril 2006; 85:78-83.
72. Kang YJ, Jeung IC, Park A, Park YJ, Jung H, Kim TD, Lee HG, Choi I, Yoon SR: An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression. Hum Reprod 2014; 29:2176-2189.
73. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE: Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 1991; 147:4398-4401.
74. Somigliana E, Vigano P, Gaffuri B, Guarneri D, Busacca M, Vignali M: Human endometrial stromal cells as a source of soluble intercellular adhesion molecule (ICAM)-1 molecules. Hum Reprod 1996; 11:1190-1194.
75. Vigano P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M: Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998; 4:1150-1156.
76. Aoki D, Katsuki Y, Shimizu A, Kakinuma C, Nozawa S: Successful heterotransplantation of human endometrium in SCID mice. Obstet Gynecol 1994; 83:220-228.
77. Illera MJ, Juan L, Stewart CL, Cullinan E, Ruman J, Lessey BA: Effect of peritoneal fluid from women with endometriosis on implantation in the mouse model. Fertil Steril 2000; 74:41-48.
78. Koujyo T, Hatakeyama S, Yamada H, Iwabuchi K, Kajino K, Ogasawara K, Onoe K, Fujimoto S: Induction of endometriosis and adenomyosis by transvaginal pituitary transplantation in mice with and without natural killer cell activity. Am J Reprod Immunol 1998; 40:441-446.
79. Ramey JW, Booker SS, Kanbour-Shakir A, Campbell AE, Sharpe-Timms KL, Archer DF: Inability to establish ectopic endometrium in a natural killer cell-deficient murine model. Immunologic, histologic and histochemical assessment. The. J Reprod Med 1996; 41:807-814.
80. Browne AS, Yu J, Huang RP, Francisco AM, Sidell N, Taylor RN: Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis. Fertil Steril 2012; 98:713-719.
81. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC: Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003; 144:2870-2881.
82. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ: Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril 2006; 85:564-572.
83. Stilley JA, Birt JA, Sharpe-Timms KL: Cellular and molecular basis for endometriosis-associated infertility. Cell Tissue Res 2012; 349:849-862.
84. Lessey BA, Lebovic DI, Taylor RN: Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects. Semin Reprod Med 2013; 31:109-124.
85. Salamonsen LA, Woolley DE: Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 1999; 44:1-27.
86. Sentman CL, Meadows SK, Wira CR, Eriksson M: Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004; 173:6760-6766.
87. McMenamin M, Lysakova-Devine T, Wingfield M, O'Herlihy C, O'Farrelly C: Endometrial aspiration biopsy: a non-invasive method of obtaining functional lymphoid progenitor cells and mature natural killer cells. Reprod Biomed Online 2012; 25:322-328.
88. Kammerer U, Marzusch K, Krober S, Ruck P, Handgretinger R, Dietl J: A subset of CD56+ large granular lymphocytes in first-trimester human decidua are proliferating cells. Fertil Steril 1999; 71:74-79.
89. King A, Balendran N, Wooding P, Carter NP, Loke YW: CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev Immunol 1991; 1:169-190.
90. Kane N, Kelly R, Saunders PT, Critchley HO: Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. Endocrinology 2009; 150:2882-2888.
91. Croy BA, Luross JA, Guimond MJ, Hunt JS: Uterine natural killer cells: insights into lineage relationships and functions from studies of pregnancies in mutant and transgenic mice. Nat Immun 1996; 15:22-33.
92. Lima PD, Zhang J, Dunk C, Lye SJ, Anne Croy B: Leukocyte driven-decidual angiogenesis in early pregnancy. Cell Mol Immunol 2014; 11:522-537.
93. Robson A, Harris LK, Innes BA, Lash GE, Aljunaidy MM, Aplin JD, Baker PN, Robson SC, Bulmer JN: Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 2012; 26:4876-4885.
94. Mariee N, Li TC, Laird SM: Expression of leukaemia inhibitory factor and interleukin 15 in endometrium of women with recurrent implantation failure after IVF; correlation with the number of endometrial natural killer cells. Hum Reprod 2012; 27:1946-1954.
95. Seshadri S, Sunkara SK: Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 2014; 20:429-438.
96. Garrido N, Navarro J, Garcia-Velasco J, Remoh J, Pellice A, Simon C: The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update 2002; 8:95-103.
97. Diaz I, Navarro J, Blasco L, Simon C, Pellicer A, Remohi J: Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril 2000; 74:31-34.
98. Sung L, Mukherjee T, Takeshige T, Bustillo M, Copperman AB: Endometriosis is not detrimental to embryo implantation in oocyte recipients. J Assist Reprod Genet 1997; 14:152-156.
99. Simon C, Martin JC, Pellicer A: Paracrine regulators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:815-826.
100. Kothapalli R, Buyuksal I, Wu SQ, Chegini N, Tabibzadeh S: Detection of ebaf, a novel human gene of the transforming growth factor beta superfamily association of gene expression with endometrial bleeding. J Clin Investig 1997; 99:2342-2350.
101. Tabibzadeh S, Mason JM, Shea W, Cai Y, Murray MJ, Lessey B: Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab 2000; 85:2526-2536.
102. Somigliana E, Vigano P, Gaffuri B, Candiani M, Busacca M, Di Blasio AM, Vignali M: Modulation of NK cell lytic function by endometrial secretory factors: potential role in endometriosis. Am J Reprod Immunol 1996; 36:295-300.
103. Somigliana E, Vigano P, Vignali M: Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? Hum Reprod Update 1999; 5:40-51.
104. Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT: Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol 2014; 72:262-269.
105. Baka S, Frangou-Plemenou M, Panagiotopoulou E, Makrakis E, Kaltsakas G, Hassiakos D, Kondi-Pafiti A: The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis. Gynecol Endocrinol 2011; 27:419-424.
106. Hornung D, Fujii E, Lim KH, Vigne JL, McMaster MT, Taylor RN: Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 2001; 75:814-817.
107. Eidukaite A, Tamosiunas V: Soluble HLA-G in the peritoneal fluid of women with endometriosis. Fertil Steril 2008; 89:465-467.
108. Basta P, Mach P, Pitynski K, Bednarek W, Klimek M, Zietek J, Zajac K, Wicherek L: Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma. Neuro Endocrinol Lett 2009; 30:91-98.
109. Barrier BF, Kendall BS, Ryan CE, Sharpe-Timms KL: HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 2006; 21:864-869.
110. Nowak I, Majorczyk E, Wisniewski A, Pawlik A, Magott-Procelewska M, Passowicz-Muszynska E, Malejczyk J, Ploski R, Giebel S, Barcz E, Zoń-Giebel A, Malinowski A, Tchórzewski H, Chlebicki A, Luszczek W, Kurpisz M, Gryboś M, Wilczyński J, Wiland P, Senitzer D, Sun JY, Jankowska R, Klinger M, Kuśnierczyk P: Does the KIR2DS5 gene protect from some human diseases? PLoS One 2010; 5:e12381.
111. Kitawaki J, Xu B, Ishihara H, Fukui M, Hasegawa G, Nakamura N, Mizuno S, Ohta M, Obayashi H, Honjo H: Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 2007; 58:481-486.
112. Iwasaki K, Makino T, Maruyama T, Matsubayashi H, Nozawa S, Yokokura T: Leukocyte subpopulations and natural killer activity in endometriosis. Int J Fertil Menopausal Stud 1993; 38:229-234.
113. Wong KH, Simon JA: In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis. Am J Obstet Gynecol 2004; 190:44-49.